Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers September 24, 2017
Pharmacy Choice - Pharmaceutical News - MyndMove FES Therapy Receives 510(k) Clearance from FDA - September 24, 2017

Pharmacy News Article

 9/8/17 - MyndMove FES Therapy Receives 510(k) Clearance from FDA

MyndTec announces it has received FDA 510(k) clearance to market MyndMove, a functional electrical stimulation (FES)-based therapy to help those with upper limb paralysis improve voluntary control of their arms and hands, in the US.

This is a major milestone in the evolution of our company, says MyndTec Founder DrMilos R. Popovic, in a media release from the Mississauga, Ontario, Canada-based company.

We are delighted that we can now offer this life-changing therapy to patients in the US with upper extremity paralysis, he adds.

The therapy system features more than 30 FES protocols that therapists can use to help enable meaningful controlled movements.

[Source(s): MyndTec, PR Newswire]

Copyright © 2017 Allied Media. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Sep 24: Using Effective Communication to Reduce Medication Errors
Last Chance
Sep 25: Management of Major Depressive Disorders
Sep 26: Vitamins, Minerals, and Electrolytes in Older Adults
Sep 27: Medication Use During Pregnancy & Lactation
Sep 28: An Integrative Approach to Managing Arthritis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement